TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -66.7% | 6,844 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +12.5% | 6,844 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -57.9% | 6,844 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -20.8% | 6,844 | 0.0% | 0.00% | – |
| Q2 2018 | $24,000 | -17.2% | 6,844 | -28.6% | 0.00% | – |
| Q1 2018 | $29,000 | -64.6% | 9,586 | -26.7% | 0.00% | – |
| Q4 2017 | $82,000 | -16.3% | 13,077 | -8.9% | 0.00% | – |
| Q3 2017 | $98,000 | +30.7% | 14,360 | +44.2% | 0.00% | – |
| Q2 2017 | $75,000 | -18.5% | 9,958 | 0.0% | 0.00% | – |
| Q1 2017 | $92,000 | +80.4% | 9,958 | -19.0% | 0.00% | – |
| Q4 2016 | $51,000 | +142.9% | 12,301 | +125.0% | 0.00% | – |
| Q3 2016 | $21,000 | -27.6% | 5,467 | -19.1% | 0.00% | – |
| Q2 2016 | $29,000 | -3.3% | 6,756 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | -55.9% | 6,756 | 0.0% | 0.00% | – |
| Q4 2015 | $68,000 | +33.3% | 6,756 | 0.0% | 0.00% | – |
| Q3 2015 | $51,000 | -79.0% | 6,756 | +23.6% | 0.00% | – |
| Q2 2015 | $243,000 | +64.2% | 5,467 | +37.0% | 0.00% | – |
| Q1 2015 | $148,000 | -9.2% | 3,991 | 0.0% | 0.00% | – |
| Q4 2014 | $163,000 | +87.4% | 3,991 | -7.8% | 0.00% | – |
| Q3 2014 | $87,000 | – | 4,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |